These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


924 related items for PubMed ID: 30894142

  • 1. Pyramidal system involvement in progressive supranuclear palsy - a clinicopathological correlation.
    Stejskalova Z, Rohan Z, Rusina R, Tesar A, Kukal J, Kovacs GG, Bartos A, Matej R.
    BMC Neurol; 2019 Mar 20; 19(1):42. PubMed ID: 30894142
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Neuropathologic basis of frontotemporal dementia in progressive supranuclear palsy.
    Sakae N, Josephs KA, Litvan I, Murray ME, Duara R, Uitti RJ, Wszolek ZK, Graff-Radford NR, Dickson DW.
    Mov Disord; 2019 Nov 20; 34(11):1655-1662. PubMed ID: 31433871
    [Abstract] [Full Text] [Related]

  • 4. Characteristics of progressive supranuclear palsy presenting with corticobasal syndrome: a cortical variant.
    Ling H, de Silva R, Massey LA, Courtney R, Hondhamuni G, Bajaj N, Lowe J, Holton JL, Lees A, Revesz T.
    Neuropathol Appl Neurobiol; 2014 Feb 20; 40(2):149-63. PubMed ID: 23432126
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Cortical atrophy differentiates Richardson's syndrome from the parkinsonian form of progressive supranuclear palsy.
    Schofield EC, Hodges JR, Macdonald V, Cordato NJ, Kril JJ, Halliday GM.
    Mov Disord; 2011 Feb 01; 26(2):256-63. PubMed ID: 21412832
    [Abstract] [Full Text] [Related]

  • 7. Progressive supranuclear palsy and corticobasal degeneration: lumping versus splitting.
    Scaravilli T, Tolosa E, Ferrer I.
    Mov Disord; 2005 Aug 01; 20 Suppl 12():S21-8. PubMed ID: 16092076
    [Abstract] [Full Text] [Related]

  • 8. Motor, cognitive and behavioral differences in MDS PSP phenotypes.
    Picillo M, Cuoco S, Tepedino MF, Cappiello A, Volpe G, Erro R, Santangelo G, Pellecchia MT, Barone P, PSP Salerno study group.
    J Neurol; 2019 Jul 01; 266(7):1727-1735. PubMed ID: 30989369
    [Abstract] [Full Text] [Related]

  • 9. Pure akinesia with gait freezing: a third clinical phenotype of progressive supranuclear palsy.
    Williams DR, Holton JL, Strand K, Revesz T, Lees AJ.
    Mov Disord; 2007 Nov 15; 22(15):2235-41. PubMed ID: 17712855
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Does corticobasal degeneration exist? A clinicopathological re-evaluation.
    Ling H, O'Sullivan SS, Holton JL, Revesz T, Massey LA, Williams DR, Paviour DC, Lees AJ.
    Brain; 2010 Jul 15; 133(Pt 7):2045-57. PubMed ID: 20584946
    [Abstract] [Full Text] [Related]

  • 12. Clinicopathological features of progressive supranuclear palsy with asymmetrical atrophy of the superior cerebellar peduncle.
    Koizumi R, Akagi A, Riku Y, Sone J, Miyahara H, Tanaka F, Yoshida M, Iwasaki Y.
    Neuropathology; 2023 Jun 15; 43(3):233-243. PubMed ID: 36222051
    [Abstract] [Full Text] [Related]

  • 13. Symptomatology in 4-repeat tauopathies is associated with data-driven topology of [18F]-PI-2620 tau-PET signal.
    Schönecker S, Palleis C, Franzmeier N, Katzdobler S, Ferschmann C, Schuster S, Finze A, Scheifele M, Prix C, Fietzek U, Weidinger E, Nübling G, Vöglein J, Patt M, Barthel H, Sabri O, Danek A, Höglinger GU, Brendel M, Levin J, for German Imaging Initiative for Tauopathies GII4T.
    Neuroimage Clin; 2023 Jun 15; 38():103402. PubMed ID: 37087820
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Incipient progressive supranuclear palsy is more common than expected and may comprise clinicopathological subtypes: a forensic autopsy series.
    Yoshida K, Hata Y, Kinoshita K, Takashima S, Tanaka K, Nishida N.
    Acta Neuropathol; 2017 May 15; 133(5):809-823. PubMed ID: 28064358
    [Abstract] [Full Text] [Related]

  • 17. Distinct involvement of the cranial and spinal nerves in progressive supranuclear palsy.
    Tanaka H, Martinez-Valbuena I, Forrest SL, Couto B, Reyes NG, Morales-Rivero A, Lee S, Li J, Karakani AM, Tang-Wai DF, Tator C, Khadadadi M, Sadia N, Tartaglia MC, Lang AE, Kovacs GG.
    Brain; 2024 Apr 04; 147(4):1399-1411. PubMed ID: 37972275
    [Abstract] [Full Text] [Related]

  • 18. Histologic tau lesions and magnetic resonance imaging biomarkers differ across two progressive supranuclear palsy variants.
    Orlandi F, Carlos AF, Ali F, Clark HM, Duffy JR, Utianski RL, Botha H, Machulda MM, Stephens YC, Schwarz CG, Senjem ML, Jack CR, Agosta F, Filippi M, Dickson DW, Josephs KA, Whitwell JL.
    Brain Commun; 2024 Apr 04; 6(2):fcae113. PubMed ID: 38660629
    [Abstract] [Full Text] [Related]

  • 19. Progressive supranuclear palsy.
    Giagkou N, Höglinger GU, Stamelou M.
    Int Rev Neurobiol; 2019 Apr 04; 149():49-86. PubMed ID: 31779824
    [Abstract] [Full Text] [Related]

  • 20. Atypical progressive supranuclear palsy underlying progressive apraxia of speech and nonfluent aphasia.
    Josephs KA, Boeve BF, Duffy JR, Smith GE, Knopman DS, Parisi JE, Petersen RC, Dickson DW.
    Neurocase; 2005 Aug 04; 11(4):283-96. PubMed ID: 16093229
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 47.